Ellevest, Inc. Syros Pharmaceuticals, Inc. Transaction History

Ellevest, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$3.26 - $4.66 $97 - $139	-30 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$4.08 - $5.66 $40 - $56	10 Added 50.0%	30 $0
Q2 2021 Jul 13, 2021	BUY	$5.01 - $7.48 $60 - $89	12 Added 150.0%	20 $0
Q4 2020 Feb 04, 2021	BUY	$6.66 - $14.66 $53 - $117	8 New	8 $0

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.